-
Medtronic announced that its Export Advance aspiration catheter received the CE Mark and will soon be available in Europe. The device is used for thrombus removal, a time sensitive procedure that requires quick access to the site of the obstruction. The Export Advance features a metal core running down...
-
Japan’s Nihon Kohden is releasing in the U.S. its new patient transport monitor. The device weighs 3.5 pounds (1.5 Kg), features a touch screen 5.5 inch (14 cm) screen, and keeps track of a 12-lead ECG, respiration, pulse oximetry, patient temperature, blood pressure, and a few other things. The...
-
BioMatrix , a company based in Singapore, received European clearance for its BioMatrix NeoFlex drug eluting stent. The device sports a new delivery system for easier navigation through vasculature and has a lower lesion entry profile than the model it’s replacing. The stent is coated in BioMatrix’s...
-
Direct Flow Medical out of Santa Rosa, California received an FDA green light to begin a feasibility trial of the company’s second-generation Transcatheter Aortic Heart Valve System in patients with aortic stenosis. The device is positioned around the stenotic valve and inflated to fully replace...
-
Thoratec received FDA clearance to offer its Pocket Controller for patients using the company’s HeartMate II LVAD (left ventricular assist device). The controller has been made lighter and smaller than previous generation models, and has an internal battery that can energize the pump at full power...
-
Preventice out of Minneapolis, Minnesota, having received FDA approval last year for remote monitoring of individuals with non-lethal cardiac arrhythmias, is launching its BodyGuardian Remote Patient Monitoring System. The core technology behind the BodyGuardian was developed at the Mayo Clinic and involves...
-
St. Jude Medical ‘s new ILUMIEN OPTIS PCI Optimization System, a tool for assessing the state of coronary arteries before stent placement, has received European approval to begin distribution on the continent. The ILUMIEN platform combines Fractional Flow Reserve (FFR) for measuring intra-arterial...
-
Elixir Medical Corporation (Sunnyvale, CA) won the European CE Mark to begin marketing its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System. The device dissolves within the vessel in about a year, leaving a properly shaped lumen that no longer requires support. Novolimus, the drug deposited...
-
Engineers at Stanford developed a tiny new sensor that is capable of monitoring the pulse with impressive resolution. About the size of a postage stamp, the device can be worn under a bandage on one of the body spots where a pulse is easily felt. The flexible pressure-sensitive organic thin film transistors...
-
Performing chest compressions in CPR is a fairly simple process easily explained to most laymen, but execution is key. You don’t want to be breaking ribs, but you certainly don’t want to under-pump the patient with even graver results. Physio-Control just launched its new TrueCPR coaching...
-
Sorin announced that it received regulatory clearance and is launching in the U.S. its SMARTVIEW Remote Monitoring System that keeps watch of the company’s Sorin PARADYM RF implanted cardiac devices. The system includes an at-home unit that communicates wirelessly with the implant and transmits...
-
Boston Scientific won the European CE Mark for its Rhythmia Mapping System, a product developed by Burlington, MA-based Rhythmia and purchased by Boston Sci last year. The mapping system takes advantage of the IntellaMap Orion catheter that features 64 electrodes to provide fast and detailed electro...
-
CARMAT (Velizy Villacoublay, France) today announced that its bioprosthetic total artificial heart is now scheduled to be trialed for the first time in human patients at four medical centers in Europe and Middle East. The CARMAT heart is intended to be used as an end-stage device, completely replacing...
-
A new highly useful app has just been released by a group of cardiologists from the University of Oklahoma called iImplant. This is a free tool designed to help health care professionals in determining the appropriateness of ICD (implantable cardioverter-defibrillator) and CRT-D (Cardiac resynchronization...
-
St. Jude Medical won FDA clearance for its Ellipse and Assura lines of implantable cardiac devices. The implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) are designed to deliver high voltage current to cardiac tissue while reducing abrasion from...